GAL-1 treatment reduced apoptosis of neurons, decreased brain infarction volume and improved neurological function induced by the ischemia, making GAL-1 a potential therapeutic target for attenuating neuronal damage and promoting recovery of brain ischemia [21]. This evidence concerns the gene GAL and ischemia.